What Bridgewater Associates LP changed, 2013 to 2026
53 quarterly 13F filings, from Q2 2013 to Q2 2026, each read from the filing itself. A quarter is compared only with the quarter before it, so a quarter with no filing is a gap in the record, not a sale.
Reported book
$24.4bn
$11.4bn at Q2 2013
Positions
997
323 at Q2 2013
Top ten weight
40%
90% at Q2 2013
Typical quarterly turnover
about 10%
Estimated from share changes
- Q2 2013: $11.4bn
- Q3 2013: $11.9bn
- Q4 2013: $12.5bn
- Q1 2014: $12.2bn
- Q2 2014: $13.3bn
- Q3 2014: $12.8bn
- Q4 2014: $12.5bn
- Q1 2015: $12.8bn
- Q2 2015: $10.8bn
- Q3 2015: $7.5bn
- Q4 2015: $7.7bn
- Q1 2016: $7.9bn
- Q2 2016: $8.0bn
- Q3 2016: $10.2bn
- Q4 2016: $10.5bn
- Q1 2017: $8.8bn
- Q2 2017: $10.9bn
- Q3 2017: $14.9bn
- Q4 2017: $12.2bn
- Q1 2018: $10.5bn
- Q2 2018: $10.0bn
- Q3 2018: $9.7bn
- Q4 2018: $10.9bn
- Q1 2019: $16.3bn
- Q2 2019: $12.8bn
- Q3 2019: $11.4bn
- Q4 2019: $9.8bn
- Q1 2020: $5.0bn
- Q2 2020: $6.0bn
- Q3 2020: $8.3bn
- Q4 2020: $11.6bn
- Q1 2021: $11.3bn
- Q2 2021: $15.6bn
- Q3 2021: $18.3bn
- Q4 2021: $17.2bn
- Q1 2022: $24.8bn
- Q2 2022: $23.6bn
- Q3 2022: $19.8bn
- Q4 2022: $18.3bn
- Q1 2023: $16.4bn
- Q2 2023: $16.2bn
- Q3 2023: $16.5bn
- Q4 2023: $17.9bn
- Q1 2024: $19.8bn
- Q2 2024: $19.2bn
- Q3 2024: $17.7bn
- Q4 2024: $21.8bn
- Q1 2025: $21.6bn
- Q2 2025: $24.8bn
- Q3 2025: $25.5bn
- Q4 2025: $27.4bn
- Q1 2026: $22.4bn
- Q2 2026: $24.4bn
- Q2 2013: 90%
- Q3 2013: 91%
- Q4 2013: 90%
- Q1 2014: 89%
- Q2 2014: 90%
- Q3 2014: 90%
- Q4 2014: 89%
- Q1 2015: 88%
- Q2 2015: 88%
- Q3 2015: 76%
- Q4 2015: 80%
- Q1 2016: 82%
- Q2 2016: 79%
- Q3 2016: 84%
- Q4 2016: 83%
- Q1 2017: 86%
- Q2 2017: 83%
- Q3 2017: 82%
- Q4 2017: 81%
- Q1 2018: 73%
- Q2 2018: 70%
- Q3 2018: 71%
- Q4 2018: 62%
- Q1 2019: 79%
- Q2 2019: 69%
- Q3 2019: 66%
- Q4 2019: 67%
- Q1 2020: 68%
- Q2 2020: 76%
- Q3 2020: 54%
- Q4 2020: 43%
- Q1 2021: 39%
- Q2 2021: 33%
- Q3 2021: 38%
- Q4 2021: 36%
- Q1 2022: 34%
- Q2 2022: 29%
- Q3 2022: 32%
- Q4 2022: 32%
- Q1 2023: 35%
- Q2 2023: 35%
- Q3 2023: 34%
- Q4 2023: 31%
- Q1 2024: 32%
- Q2 2024: 35%
- Q3 2024: 32%
- Q4 2024: 43%
- Q1 2025: 32%
- Q2 2025: 36%
- Q3 2025: 33%
- Q4 2025: 36%
- Q1 2026: 41%
- Q2 2026: 40%
The positions that defined it
Every position that was ever among the 25 largest: when it first appeared, when it was largest, and where it stands in Q2 2026. The line is its reported value each quarter.
| Position | Value over time | First listed | Largest | Q2 2026 |
|---|---|---|---|---|
| Spdr S&P 500 Etf Trust(SPY) | Q2 2013 | $4.8bnQ4 2024 | $4.0bn | |
| iShares Core S&P500 ETF(IVV) | Q2 2013 | $2.9bnQ4 2025 | $2.2bn | |
| Nvidia Corp(NVDA) | Q2 2013 | $1.1bnQ2 2025 | $774m | |
| Broadcom Inc(AVGO) | Q1 2022 | $568mQ1 2026 | $498m | |
| Amazon Com Inc(AMZN) | Q1 2014 | $914mQ1 2026 | $483m | |
| Alphabet Inc(GOOGL)Capital Stock Class A | Q1 2016 | $987mQ2 2025 | $473m | |
| Lam Research Corp(LRCX) | Q4 2024 | $521mQ4 2025 | $407m | |
| Vanguard Index S&P 500 ETF Shares(VOO) | Q2 2024 | $315mQ2 2026 | $315m | |
| Advanced Micro Devices Inc(AMD) | Q4 2019 | $355mQ4 2025 | $313m | |
| iShares MSCI South Korea ETF(EWY) | Q3 2016 | $280mQ2 2026 | $280m | |
| Microsoft Corp(MSFT) | Q2 2013 | $853mQ2 2025 | $266m | |
| Newmont Mining Corp(NEM) | Q2 2013 | $252mQ2 2026 | $252m | |
| iShares MSCI Emerging Markets ETF(EEM) | Q3 2013 | $3.3bnQ3 2014 | Below the listed rangelast listed Q2 2024 | |
| iShares MSCI Emerg MKT(EEM) | Q2 2013 | $3.1bnQ2 2013 | Below the listed rangelast listed Q2 2013 | |
| SPDR Gold Trust(GLD) | Q2 2017 | $968mQ3 2020 | Soldlast listed Q2 2025 | |
| Alibaba Group HLDG LTD(BABA)Sponsored ADS | Q2 2018 | $814mQ1 2022 | Soldlast listed Q1 2025 | |
| iShares Core Sp500 ETF(IVV) | Q4 2021 | $644mQ2 2022 | Below the listed rangelast listed Q2 2022 | |
| iShares MSCI Brazil ETF(EWZ) | Q4 2017 | $535mQ3 2019 | Soldlast listed Q3 2024 | |
| Salesforce Com Inc(CRM) | Q1 2014 | $512mQ4 2025 | Soldlast listed Q4 2025 | |
| Pinduoduo Inc(PDD)Sponsored ADS | Q2 2019 | $357mQ4 2023 | Soldlast listed Q1 2025 |
Quarter by quarter
Q2 2018: $10.0bn across 460 positions
Against Q1 2018: 93 new, 126 added to, 225 trimmed, 93 sold out, across all 460 positions.
Turnover about 11% of the book, estimated from share changes at quarter-end prices.
Largest additions
- Toronto Dominion BK Ont (TD)+$32m
- Royal BK Cda Montreal Que (RY)+$32m
- iShares Core MSCI Emkt (IEMG)+$31m
- Toll Brothers Inc (TOL)+$28m
- Chevron Corp New (CVX)+$23m
- McDonald's Corp (MCD)+$22m
- Suncor Energy Inc New (SU)+$21m
- Te Connectivity LTD+$21m
Largest reductions
- Vanguard Intl Equity Index Ftse EMR MKT ETF (VWO)-$318m
- iShares MSCI Emerging Markets ETF (EEM)-$233m
- Spdr S&P 500 Etf Trust (SPY)-$75m
- Newfield Expl Co-$24m
- Facebook Inc (META)-$23m
- Southwestern Energy Co-$21m
- Cleveland Cliffs Inc (CLF)-$19m
- Bed Bath & Beyond Inc-$17m
Opened
Nothing new among the largest positions.
Sold out
- Procter & Gamble Co (PG)was $31m
- General Electric Cowas $20m
- Davita Healthcare Partners I (DVA)was $15m
- Transocean LTD (RIG)was $13m
- Pepsico Inc (PEP)was $11m
- Campbell Soup Co (CPB)was $11m
- Amgen Inc (AMGN)was $11m
- Freeport-mcmoran Copper & Go (FCX)was $9.4m
Largest positions, Q2 2018
The largest 25 of 460 reported positions.
| Position | Value | Weight | On the quarter |
|---|---|---|---|
| Spdr S&P 500 Etf Trust (SPY) | $2.3bn | 22.7% | Trimmed |
| Vanguard Intl Equity Index Ftse EMR MKT ETF (VWO) | $2.1bn | 21.0% | Trimmed |
| iShares Core MSCI Emkt (IEMG) | $554m | 5.5% | Added |
| SPDR Gold Trust (GLD) | $464m | 4.6% | Held |
| iShares MSCI Emerging Markets ETF (EEM) | $322m | 3.2% | Trimmed |
| iShares MSCI Brazil ETF (EWZ) | $294m | 2.9% | Added |
| iShares IBOXX INV CP ETF (LQD) | $287m | 2.9% | Held |
| iShares 20 Year Treasury Bond ETF (TLT) | $240m | 2.4% | Held |
| iShares Core S&P500 ETF (IVV) | $220m | 2.2% | Held |
| iShares IBOXX High Yield ETF (HYG) | $214m | 2.1% | Held |
| iShares JPMorgan USD EMG (EMB) | $188m | 1.9% | Held |
| Vanguard Tax Managed Intl FD Ftse DEV MKT ETF (VEA) | $166m | 1.7% | Held |
| iShares MSCI EAFE ETF (EFA) | $164m | 1.6% | Held |
| iShares Core MSCI EAFE (IEFA) | $151m | 1.5% | Held |
| iShares Gold Trust | $136m | 1.4% | Held |
| iShares Tips BD ETF (TIP) | $126m | 1.3% | Held |
| Royal BK Cda Montreal Que (RY) | $45m | 0.4% | Added |
| CVS Caremark Corporation (CVS) | $45m | 0.4% | Added |
| Toronto Dominion BK Ont (TD) | $44m | 0.4% | Added |
| Celgene Corp | $43m | 0.4% | Added |
| AT&T Inc (T) | $41m | 0.4% | Added |
| Walgreens Boots Alliance Inc | $39m | 0.4% | Added |
| Toll Brothers Inc (TOL) | $38m | 0.4% | Added |
| Cardinal Health Inc (CAH) | $37m | 0.4% | Added |
| iShares MSCI Taiwan ETF (EWT) | $35m | 0.4% | Trimmed |
The books most like this one
Among the managers whose filings are on file, at Q2 2026. Overlap is the share of the two books that is the same: for every stock both list, the smaller of its two weights, added up. Two books can overlap because both own the largest companies; it says nothing about whether the managers agree.
| Manager | Overlap | Stocks in both | Overlap over time | |
|---|---|---|---|---|
| Invesco Ltd | at least 32% | 233 | Compare | |
| AQR Capital Management LLC | at least 31% | 252 | Compare | |
| Arrowstreet Capital LP | at least 30% | 227 | Compare | |
| T. Rowe Price Associates Inc | at least 30% | 213 | Compare | |
| Man Group PLC | at least 30% | 217 | Compare | |
| Fidelity (FMR LLC) | at least 29% | 214 | Compare | |
| Neuberger Berman Group LLC | at least 28% | 180 | Compare | |
| MFS Investment Management | at least 28% | 202 | Compare |
“At least” where either manager has more positions than are read each quarter: a stock both hold below that range is not counted.
The filings behind it
Every quarter above is one 13F holdings report, with any amendment the filer made to it applied in the order it was filed. Where the reporting entity changed, each quarter keeps the filer that actually reported it.
| Quarter | Filer | Book | Amended | Filing |
|---|---|---|---|---|
| Q2 2026 | Bridgewater Associates LP | $24.4bn | 13F-HR | |
| Q1 2026 | Bridgewater Associates LP | $22.4bn | 13F-HR | |
| Q4 2025 | Bridgewater Associates LP | $27.4bn | 13F-HR | |
| Q3 2025 | Bridgewater Associates LP | $25.5bn | 13F-HR | |
| Q2 2025 | Bridgewater Associates LP | $24.8bn | 13F-HR | |
| Q1 2025 | Bridgewater Associates LP | $21.6bn | 13F-HR | |
| Q4 2024 | Bridgewater Associates LP | $21.8bn | 13F-HR | |
| Q3 2024 | Bridgewater Associates LP | $17.7bn | 13F-HR | |
| Q2 2024 | Bridgewater Associates LP | $19.2bn | 13F-HR | |
| Q1 2024 | Bridgewater Associates LP | $19.8bn | 13F-HR | |
| Q4 2023 | Bridgewater Associates LP | $17.9bn | 13F-HR | |
| Q3 2023 | Bridgewater Associates LP | $16.5bn | 13F-HR | |
| Q2 2023 | Bridgewater Associates LP | $16.2bn | 13F-HR | |
| Q1 2023 | Bridgewater Associates LP | $16.4bn | 13F-HR | |
| Q4 2022 | Bridgewater Associates LP | $18.3bn | 13F-HR | |
| Q3 2022 | Bridgewater Associates LP | $19.8bn | 13F-HR | |
| Q2 2022 | Bridgewater Associates LP | $23.6bn | 13F-HR | |
| Q1 2022 | Bridgewater Associates LP | $24.8bn | 13F-HR | |
| Q4 2021 | Bridgewater Associates LP | $17.2bn | 13F-HR | |
| Q3 2021 | Bridgewater Associates LP | $18.3bn | 13F-HR | |
| Q2 2021 | Bridgewater Associates LP | $15.6bn | 13F-HR | |
| Q1 2021 | Bridgewater Associates LP | $11.3bn | 13F-HR | |
| Q4 2020 | Bridgewater Associates LP | $11.6bn | 13F-HR | |
| Q3 2020 | Bridgewater Associates LP | $8.3bn | 13F-HR | |
| Q2 2020 | Bridgewater Associates LP | $6.0bn | 13F-HR | |
| Q1 2020 | Bridgewater Associates LP | $5.0bn | 13F-HR | |
| Q4 2019 | Bridgewater Associates LP | $9.8bn | 13F-HR | |
| Q3 2019 | Bridgewater Associates LP | $11.4bn | 13F-HR | |
| Q2 2019 | Bridgewater Associates LP | $12.8bn | 13F-HR | |
| Q1 2019 | Bridgewater Associates LP | $16.3bn | 13F-HR | |
| Q4 2018 | Bridgewater Associates LP | $10.9bn | 13F-HR | |
| Q3 2018 | Bridgewater Associates LP | $9.7bn | 13F-HR | |
| Q2 2018 | Bridgewater Associates LP | $10.0bn | 13F-HR | |
| Q1 2018 | Bridgewater Associates LP | $10.5bn | 2 | 13F-HR |
| Q4 2017 | Bridgewater Associates LP | $12.2bn | 13F-HR | |
| Q3 2017 | Bridgewater Associates LP | $14.9bn | 13F-HR | |
| Q2 2017 | Bridgewater Associates LP | $10.9bn | 13F-HR | |
| Q1 2017 | Bridgewater Associates LP | $8.8bn | 13F-HR | |
| Q4 2016 | Bridgewater Associates LP | $10.5bn | 13F-HR | |
| Q3 2016 | Bridgewater Associates LP | $10.2bn | 13F-HR | |
| Q2 2016 | Bridgewater Associates LP | $8.0bn | 13F-HR | |
| Q1 2016 | Bridgewater Associates LP | $7.9bn | 13F-HR | |
| Q4 2015 | Bridgewater Associates LP | $7.7bn | 13F-HR | |
| Q3 2015 | Bridgewater Associates LP | $7.5bn | 13F-HR | |
| Q2 2015 | Bridgewater Associates LP | $10.8bn | 13F-HR | |
| Q1 2015 | Bridgewater Associates LP | $12.8bn | 13F-HR | |
| Q4 2014 | Bridgewater Associates LP | $12.5bn | 13F-HR | |
| Q3 2014 | Bridgewater Associates LP | $12.8bn | 13F-HR | |
| Q2 2014 | Bridgewater Associates LP | $13.3bn | 13F-HR | |
| Q1 2014 | Bridgewater Associates LP | $12.2bn | 13F-HR | |
| Q4 2013 | Bridgewater Associates LP | $12.5bn | 13F-HR | |
| Q3 2013 | Bridgewater Associates LP | $11.9bn | 13F-HR | |
| Q2 2013 | Bridgewater Associates LP | $11.4bn | 13F-HR |
Reading this record
A 13F lists US-listed long equity and options at the quarter end, filed up to 45 days later. It shows what was held, not when it was bought or at what price, and nothing short. Where a quarter lists only the largest positions, a name missing from it may still be held below that range; the counts of what was opened and sold always cover the whole filing.
Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More